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Our previous results showed that the polysaccharides extracted from Lycium barbarum (LBP) could delay sec-
ondary degeneration of retinal ganglion cell bodies and improve the function of the retinas after partial optic
nerve transection (PONT). Although the common degeneration mechanisms were believed to be shared by
both neuronal bodies and axons, recently published data from slow Wallerian degeneration mutant (Wlds)
mice supported the divergence in the mechanisms of them. Therefore, we want to determine if LBP could
also delay the degeneration of axons after PONT. Microglia/macrophages were thought to be a source of
reactive oxygen species after central nervous system (CNS) injury. After PONT, however, oxidative stress
was believed to occur prior to the activation of microglia/macrophages in the areas vulnerable to secondary
degeneration both in the optic nerves (ONs) and the retinas. But the results did not take into account the
morphological changes of microglia/macrophages after their activation. So we examined the morphology in
addition to the response magnitude of microglia/macrophages to determine their time point of activation. In
addition, the effects of LBP on the activation of microglia/macrophages were investigated. The results
showed that (1) LBP reduced the loss of axons in the central ONs and preserved the g-ratio (axon diameter/
fiber diameter) in the ventral ONs although no significant effect was detected in the dorsal ONs; (2)
microglia/macrophages were activated in the ONs by 12 h after PONT; (3) LBP decreased the response
magnitude of microglia/macrophages 4 weeks after PONT. In conclusion, our results showed that LBP could
delay secondary degeneration of the axons, and LBP could also inhibit the activation of microglia/macro-
phages. Therefore, LBP could be a promising herbal medicine to delay secondary degeneration in the CNS
via modulating the function of microglia/macrophages.
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INTRODUCTION
In addition to primary degeneration, secondary degen-
eration of the neurons and glial cells in the central nervous
system (CNS) occurred under various pathological condi-
tions such as brain trauma, spinal cord injury, stroke, and
chronic neurodegenerative diseases, including Alzheimer’s
disease, Parkinson’s disease, Huntington’s disease, and
glaucoma (3,18,33,38,43,45,46,53). The retinal ganglion
cells (RGCs) are vulnerable to secondary degeneration in
glaucoma, making them a promising target of neuroprotection
in order to delay the death of RGCs. However, it is difficult
to distinguish secondary degeneration from primary degen-
eration in glaucoma patients and also in animal models cur-
rently used for the study of glaucoma, including optic nerve
(ON) crush, complete ON transection, and ocular hyper-
tension models. There is neither a clear boundary nor an
effective distinguishing method between the primary degen-
eration and secondary degeneration. However, a new model
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established in the last decade, the partial optic nerve tran-
section (PONT) model, contributed to resolve this issue. In
this model, only the dorsal part of the ON was transected,
and the central and ventral parts of the ON remained intact.
It was useful for the study of secondary degeneration in the
retinas and ONs because the primary and secondary degen-
eration could be distinguished in location (15,16,28,29,31).
Lycium barbarum has been used as an “upper class
medical herb” for hundreds of years in the Oriental
world. It can treat diseases related to vision, the kidney,
and the liver in Chinese medical theory (24). In our lab-
oratory, we use Lycium barbarum bought from the Ning
Xia Huizu Autonomous Region, People’s Republic of
China. We have previously shown that the polysaccha-
rides extracted from Lycium barbarum (LBP) reduced
the death of cultured cortical neurons challenged by b-
amyloid, glutamate, and homocysteine (23,54–56) and
alleviated depression of rats by enhancing synaptic plas-
ticity (57). LBP also delayed the degeneration of RGCs
in the acute ischemia/reperfusion model (20,36), the
chronic ocular hypertension model (5,35,37), and the
mouse transient middle cerebral artery occlusion model
(32). However, whether LBP delayed primary or second-
ary degeneration in these models and the mechanism(s)
underlying the neuroprotective effects of LBP remained
unclear. Using the PONT model of Sprague–Dawley (SD)
rats, we have shown that LBP could decrease the second-
ary degeneration of the cell bodies of RGCs 4 weeks
after PONT in the retinas, and it might exert its roles
through inhibiting oxidative stress and activation of c-Jun
N-terminal kinase (JNK) pathway (30). In addition, our
study showed that LBP could improve the function of
both the inner (RGCs) and outer retinas (bipolar cells and
photoreceptors) affected by PONT using measurements
from multifocal electroretinograms (9). However, the
effect of LBP on the axonal degeneration in the ONs of
SD rats has not been elucidated. The mechanisms of
degeneration underlying the axons and RGC bodies might
not be identical according to a lot of evidence using slow
Wallerian degeneration mutant (Wlds) mice (10,11,26,49,50).
For example, in Wlds mutant mice and transgenic rats,
the axons in the ONs were protected after ON injury or
ocular hypertension, whereas the somata in the retinas
were not (2,34,48). Although Wallerian degeneration (the
degeneration of axons distal to the injury site) was inves-
tigated in these studies, the retrograde degeneration of the
ONs shared the same mechanisms with Wallerian degen-
eration (25). In Wistar rats, the degeneration of axons was
believed to follow a similar time course to that of the RGC
bodies after PONT; however, the loss percentages were dif-
ferent between the axons and the cell bodies at several
time points (29). Damage to RGC axons often led to the
retrograde degeneration of the cell bodies in the retinas
(40). Therefore, it was an indispensable complement to
investigate the effects of LBP on the degeneration of
axons after PONT in addition to the degeneration of RGC
bodies that we have previously done.
Evidence showed that the oxidative stress, activation of
microglia, and infiltration of macrophages were precedent
to the secondary loss of axons after PONT (29). Microglia/
macrophages were indicated to be a source of reactive
oxygen species (ROS) after CNS damage (4). However, the
synchronous occurrence of oxidative stress (indicated by
the increased labeling intensity of mitochondrial superox-
ide dismutase) and activation of microglia/macrophages
[based on the increased ionized calcium-binding adapter
molecule 1 (Iba-1)-positive cell counting] were not con-
firmed in the PONT model, and the former was much ear-
lier (5 min) than the latter (3 days). Therefore, activated
microglia/macrophages were stated to not participate in the
oxidative stress after PONT (16). However, in fact, the acti-
vation of microglia/macrophages could also be discerned
based on their morphology. The responding microglia/
macrophages can be divided into the semiactivated state
and the fully activated state according to their morphology
(13). In order to find out whether microglia/macrophage
activation was earlier based on their morphology than based
on quantitative analysis, the morphology of microglia/
macrophages after Iba-1 labeling was observed after PONT.
LBP could modulate the activation of microglia/macrophages
to exert neuroprotection in our previous study in a rat
chronic ocular hypertension model (8). In order to find out
if LBP protection in the PONT model was related to its
modulation of microglia/macrophages, the effects of LBP
on the long-term responses of microglia/macrophages were
investigated 4 weeks after PONT, since LBP delayed sec-
ondary degeneration of axons at this time point.
MATERIALS AND METHODS
Animals
Adult female SD rats (10–12 weeks of age, weighing
250–280 g, provided by the Laboratory Animal Unit, the
Hong Kong University, Hong Kong, China) were used in
this study. The rats were housed in a temperature-controlled
room subjected to a 12-h light/12-h dark cycle and supplied
with food and water ad libitum. Normal rats without PONT
and without feeding with phosphate-buffered saline (PBS;
0.01 M, pH 7.4) or 1 mg/kg (rat weight) LBP in PBS were
used for the control in all the experiments in this study.
The PBS (0.01 M, pH 7.4) was prepared from 0.1 M
phosphate buffer (PB; pH 7.4), which was prepared from
sodium phosphate dibasic dodecahydrate and sodium
phosphate monobasic monohydrate (Sigma-Aldrich, St.
Louis, MO, USA) and sodium chloride (Affymetrix USB,
Brockville, Canada). The preparation of LBP powder was
as previously described (56). The LBP powder was stored
in a dry box and freshly dissolved in PBS before use. To
investigate the reaction of microglia/macrophages after
404 LI ET AL.
PONT, the normal control rats (n = 4) and the rats without
treatment with PBS or LBP were sacrificed after PONT
at different time points (12 h, 1 day, 4 days, 1 week, and
4 weeks; n = 4 in each group). Frozen sections of the ONs
were prepared for immunohistochemistry staining. For
studying the effect of LBP, the rats were fed with PBS or
LBP 1 week before PONT and sacrificed 4 weeks after
PONT. The treatment was achieved with a feeding needle
(F.S.T., Heidelberg, Germany) by gavage once daily. There
were two sets of animals (either set including the normal
control, PBS, and LBP groups): one set was used for the
axonal counting, and semithin and ultrathin sections of the
ONs were prepared (n = 5 in each group); the other set
was used for Iba-1 labeling to detect the effect of LBP on
the function of microglia/macrophages, and frozen sec-
tions of the ONs were prepared for immunohistochemis-
try staining (n = 4 in the normal control group; n = 5 in
either the PBS or the LBP group). The use of animals
followed the requirements of the Cap. 340 Animals (Con-
trol of Experiments) Ordinance and Regulations in Hong
Kong. All the experimental and animal handling proce-
dures were approved by the Faculty Committee on the Use
of Live Animals in Teaching and Research in The Uni-
versity of Hong Kong (CULATR #1850-09 and #1996-09).
PONT Surgery
The PONT surgery was performed as described previ-
ously (6,30). A partial incision 1.0 mm from the optic disc
was made in the ONs using a pair of Spring Vannas scis-
sors (15000-08; F.S.T., Heidelberg, Germany) as described
previously (30) in the animals used for transmission elec-
tron microscope (TEM) analysis. A custom-made thin blade
from razors was used for partial cut of the ONs in another
set of animals used for immunohistochemistry staining
(6). A marker at 200 mm from the tips of the blades or
scissors was made to help limit the extent of the cut
(Fig. 1). The axons in the directly damaged sites (the dor-
sal one third of the ONs) would undergo primary degen-
eration and the axons in the indirectly damaged sites (the
central one third and ventral one third of the ONs) would
undergo secondary degeneration (Fig. 1).
Preparation of Semithin and Ultrathin Sections of ONs
Animals were anesthetized using an overdose intraperito-
neal injection of pentobarbitone and perfused transcardially
with normal saline, followed by 4% paraformaldehyde
(PFA; International Laboratory USA, South San Francisco,
CA, USA) in 0.1 M PB. The ONs from normal control rats
and rats fed with 0.01 M PBS or LBP 1 week before PONT
until 4 weeks after surgery (n = 5 in each group) were
removed as close to the eyeballs as possible after sacri-
fice and postfixed in 2% PFA and 2.5% glutaraldehyde
(Merck KGaA, Darmstadt, Germany) in 0.1 M PB for 24 h.
Then the ONs were further postfixed in 1% osmium
tetroxide (Electron Microscopy Sciences, Hatfield, PA, USA)
in 0.1 M PB for 2.5 h, dehydrated with graded series of
ethanol (30%, 50%, 70%, 80%, 90%, 95%, and 100%),
infiltrated with propylene oxide (PO, Electron Microscopy
Sciences), 1:1 mixture of PO and epoxy resin (Emgrid
Australia Pty Ltd., The Patch, VIC 3792, Australia), and
then embedded in pure epoxy resin. Semithin sections of
0.5 mm in thickness were obtained from the end of the
ON segments close to the eyeball and stained with 1%
toluidine blue (Bio-Rad, Life Science Research, Hercules,
CA, USA). Then the sections were observed under light
microscope to determine the orientation of the ON, which
was marked on the resin block before performing ultra-
thin sections. The double contrast method was used for
ultrathin section (100 nm) staining. The ultrathin sections
were stained with 2% uranyl acetate (Polysciences, Inc.,
Warrington, PA, USA) for 20 min, followed by lead cit-
rate (Thermo Fisher Scientific Inc., Waltham, MA, USA)
for 10 min for observation, and photographs were taken
under TEM (Philip CM 100 TEM: Electron Microscope
Unit, HKU).
TEM Analysis of Axons and Myelin
This method was modified from that described by
Payne et al. (39). After confirmation of the transverse orien-
tation of the ON by observation under low power using the
TEM, each ON was divided visually into three roughly
equal areas: dorsal third, central third, and ventral third. In
each area, 10 high-power images (5,800× magnification)
were selected for analysis (Fig. 2). Total number of axons
in each photograph with the size of 15.5 µm × 15.5 µm
was calculated using ImageJ software (NIH, Bethesda, MD,
USA) and then the average density (axon numbers/mm2)
was determined in each area. The g-ratio (axon diameter/
nerve fiber diameter) and myelin thickness were calculated
in the ventral ONs by randomly selecting 400 to 500 nor-
mally myelinated axons (thick, compact, high electrodensity
myelin) (39) in each animal (40 to 50 axons in each image)
with ImageJ software. The axons and nerve fibers (axon
plus myelin) were not circular, so the diameter of each axon
or nerve fiber was derived from a circle with the equal area
to the axon or nerve fiber, and the g-ratio is obtained by
dividing the diameter of an axon with the diameter of the
nerve fiber (17,19,42). Myelin thickness was obtained by
subtracting the axon diameter from the fiber diameter and
dividing by two (39).
Immunohistochemistry Staining Protocol
and Analysis of Results
Animals were sacrificed with an overdose of pheno-
barbital (Alfasan International B.V., Woerden, Holland)
followed by transcardial perfusion with 0.9% saline followed
by 4% PFA in 0.1 M PB. The segments of ON about
2.5 mm in length, including the ends closest to the
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eyeballs, the cut sites, and the ends distal to the cut loca-
tion, were dissected and postfixed in 4% PFA for 24 h at
4°C, cryoprotected by immersion in 30% sucrose (Sigma-
Aldrich) in PB overnight, embedded in optimal cutting
temperature compound (Tissue Tek; OpticsPlanet, Inc.,
Northbrook, IL, USA), and serially cryosectioned trans-
versely (16 um) in 10 sets with about 16 sections in each
set. Then the ON sections were air dried, rehydrated in
PBS, blocked with 10% normal goat serum (Invitrogen,
Fisher Scientific UK Ltd., Loughborough, UK) for 1 h,
and incubated overnight at 4°C in primary antibodies
detecting b-III tubulin (1:500 TUJ1 antibody clone,
mouse monoclonal; Convance, Emeryville, CA, USA)
and microglia/macrophages (1:800 Iba-1, rabbit poly-
clonal; Wako, Osaka, Japan). The TUJ1 antibody clone is
used for staining neuron-specific class III b-tubulin and
therefore can label the axons in the ON and show the
structure of ONs. Iba-1 can detect resting and activated
microglia and macrophages. Signals were visualized by
reacting with corresponding fluorescent secondary anti-
bodies (1:400; Invitrogen, Fisher Scientific) for 2 h at
room temperature. Then the sections were washed and
coverslipped for examination. The ratios of the immu-
nohistochemistry-positive labeling area of Iba-1 to the
whole area in the ON transverse section were determined
using ImageJ software using a modified method described
Figure 1. Schematic diagram showing the surgery of PONT. The partial incision in the ON was made 1.0 mm from the optic disc
and was achieved using a pair of Spring Vannas scissors or using a custom-made sharp blade from razors; both were provided with
a marker at 200 mm from the tips of blades. The axons in the direct damaged sites (dorsal one third of the ONs in the transverse
sections from the cut site and the sites before the cut) would undergo primary degeneration, and the axons in the indirect damaged
sites (central one third and ventral one third of the ONs in the transverse sections from the cut site and the sites before the cut)
would undergo secondary degeneration.
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previously (14). The ratios of the immunohistochemistry-
positive labeling area of Iba-1 in each one third of the
ONs to the total area of each one third of the ONs (the
dorsal, central, and ventral ONs) were determined using
the same method.
Statistical Analysis
All data were expressed as the mean ± standard error of
the mean (SEM). One-way ANOVA was used for multiple
comparisons followed by Dunn’s or Student–Newman–Keuls
(SNK) method as post hoc tests. Data were analyzed statis-
tically with the Sigmastat software (Sigmastat 3.5; Systat Soft-
ware Inc., Chicago, IL, USA). The level of p = 0.05 was
considered to be statistically significant.
RESULTS
LBP’s Effect on the Degeneration of Optic Fibers
Under the Philips CM100 TEM, all ON fibers showed
intact morphology with normal myelin in the dorsal part,
the central part, and the ventral part in the normal ONs
(Fig. 3A–C). The average densities of total axons in the
dorsal, central, and ventral areas in the normal group were
568,970 ± 47,050 axons/mm2, 588,860 ± 36,660 axons/mm2,
and 580,040 ± 34,160 axons/mm2, respectively (Fig. 4A).
In the PBS group 4 weeks after PONT, the morphology of
the axons and myelin changed significantly. In the dorsal
part of the ONs (primary injury site), the loss of axons was
severe, and the average density of axons in the dorsal areas
was 284,400 ± 29,310 (Fig. 4A). The dark degeneration
(arrow in Fig. 3D) and watery degeneration (white asterisk
in Fig. 3D) could be seen. The definition of dark and watery
degeneration has been described by Saggu et al. (41). In
addition, the axonal regions were replaced by many macro-
phages (arrowhead in Fig. 3D) and empty spaces (black
asterisks, Fig. 3D). In the central part (secondary injury site
close to primary injury site), the loss of axons was still obvious
but not as severe as in the dorsal ONs, and the average den-
sity was 366,990 ± 78,150 axons/mm2 (Fig. 4A). Many
empty spaces (black asterisk, Fig. 3E) and broken myelin
(white asterisk, Fig. 3E) appeared in the area, but some axons
showed intact structure with slight atrophy (arrow, Fig. 3E).
In the ventral part (the secondary injury site further from the
primary injury site), the loss of axons was not obvious in the
PBS group, and the average density of axons was
519,600 ± 73,320 axon/mm2 (Fig. 4A). However, most of the
axons were slightly shrunken (arrow, Fig. 3F). In the LBP
group, the extent of axonal loss in the dorsal ON was similar
to that of the PBS group, and the average density of axons
was 253,350 ± 34,550 axons/mm2 (Figs. 3G and 4A). The
dark degeneration (arrow in Fig. 3G) could be seen, and the
Figure 2. Schematic diagram showing the location where photographs were taken for axonal counting and g-ratio calculation. Ten
high-power (5,800×) TEM images (represented by squares in the figure) within the dorsal, central, and ventral parts of ONs were
used for analysis.
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axonal regions were replaced by many macrophages (arrow-
head in Fig. 3G). In the central and ventral ONs, the loss of
axons was not obvious compared with the normal group,
and the average density of axons were 632,240 ± 45,940
axons/mm2 and 561,630 ± 61,710 axons/mm2, respectively
(Figs. 3H, I and 4A). Although the densities of axons in the
normal, PBS, and LBP groups were similar in the ventral
ONs (Fig. 4A), the g-ratio in the ventral ONs decreased
significantly in the PBS group (0.63 ± 0.04) compared with
the LBP group (0.72 ± 0.01) and normal group (0.76 ± 0.01),
whereas the myelin thickness remained unchanged (Fig. 4B,
C). The average thickness of myelin in normal, PBS, and
LBP groups were 0.14 ± 0.011 mm, 0.16 ± 0.007 mm, and
0.15 ± 0.007 mm, respectively (Fig. 4C). However, the mor-
phology of axons in the ventral part in the LBP group was
similar to that in the normal group (Fig. 3C and I).
Figure 3. Micrographs showing morphological changes of ONs through transverse sections under TEM. All ON fibers show intact
morphology with normal myelin in the dorsal part (A), the central part (B), and the ventral part (C) in the normal ON. In the PBS
(vehicle control) group 4 weeks after PONT, the morphology of the axons and myelin change significantly. In the dorsal ON, only
a few axons can be seen in the PBS group. The dark degeneration (arrow in D) and watery degeneration (white asterisk in D) can
be seen. In addition, the axonal regions are replaced by many macrophages (arrowhead in D) and empty spaces (black asterisk in
D). In the central part (secondary injury site close to primary injury site), many empty spaces (black asterisk, E) and broken myelin
(white asterisk, E) appear in the area, but some axons show intact structure but slightly shrunken (arrow, E). In the ventral part (the
secondary injury site further from the primary injury site), most of the axons were slightly shrunken (arrow, F). In the LBP group,
the extent of axonal loss in the dorsal ON was similar to that of the PBS group (G). The dark degeneration (arrow in G) can be
seen, and the axonal regions are replaced by many macrophages (arrowhead in G). In the central and ventral ON, the loss of axons
was not obvious compared with the normal group (H, I). The morphology of axons in the ventral part in the LBP group is almost
similar to that in the normal group (I).
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Figure 4. The effects of LBP on primary and secondary degeneration of ON fibers. (A) The axon densities decreased significantly
in the PBS and LBP groups in the dorsal ONs 4 weeks after PONT, but there was no significant difference between the PBS and
LBP groups. The axon densities decreased significantly in the PBS group in the central parts compared with the normal and LBP
groups 4 weeks after PONT. There was no significant difference between the normal and LBP groups. The axon densities were
similar among the normal, PBS, and LBP groups in the ventral parts 4 weeks after PONT (one-way ANOVA, SNK method for
multiple comparisons: #p < 0.001; *p < 0.05; NS, no significance, n = 5 in each group). (B) The g-ratio decreased in the PBS group
in the ventral parts of ON 4 weeks after PONT compared with normal and LBP groups (one-way ANOVA, SNK method for multi-
ple comparisons: *p < 0.05; NS, no significance, n = 5 in each group). (C) Myelin thickness remained similar among normal, PBS,
and LBP groups 4 weeks after PONT (one-way ANOVA: NS, no significance, n = 5 in each group).
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Response of Microglia/Macrophages to PONT
In the present study, we firstly employed b-III tubulin
immunostaining to identify the morphology of the trans-
verse sections of the ONs. Figure 5 showed that dorsal
fibers of the ON were disrupted at the injury sites. The
sections with the intact profiles, which were closer to the
eyeball than the cut sites, were stained with Iba-1 to eval-
uate the response of microglia/macrophages to PONT
(Fig. 6). The reason to select this location was that the
transected axons kept their pathway from the cut site to
the eyeball by the lipophilic membrane dye DiI tracing in
vivo in SD rats (30). Therefore, the primary and secondary
injury location was kept in the transverse sections of the
ONs from the cut site to the eyeball. In addition, the
ultrathin sections for axonal counting were also examined
at a location closer to the eyeball than the cut sites.
Iba-1 is a calcium-binding protein expressed mainly in
resting and activated microglia and macrophages and is
Figure 5. The morphology of the transverse sections of ONs stained with b-III tubulin from the cut sites. (A) The profile of the
normal ON from the cut site. The profile was intact, and the border was smooth. (B–F) The profiles of ONs were disrupted at
12 h (B), 1 day (C), 4 days (D), 1 week (E), and 4 weeks (F) after PONT. The protrusion could be seen from the dorsal part where the
cut was made (indicated by arrows) (scale bar: 100 µm).
FACING PAGE
Figure 6. The morphology of Iba-1-positive microglia/macrophages. (A–F, scale bar: 100 µm) The whole distribution of Iba-1-pos-
itive labeling in the normal ONs and ONs after PONT. The d, c, and v represent the dorsal third, central third, and ventral third in
each time point. The distribution of Iba-1-positive cells was almost even in the dorsal, central, and ventral parts in the normal ONs
(A). It was similar in the ONs 12 h and 1 day after PONT (B, C). There were obviously more Iba-1-positive cells both in the dorsal
and central ONs 4 days and 1 week after PONT compared with ventral ONs (D, E). Four weeks after PONT, more positive cells in
the dorsal ON compared with the central and ventral ONs (F). (G–X, scale bar: 25 µm) The morphology of Iba-1-positive cells in
each third of the ONs of normal animals (G–I) and animals 12 h (J–L), 1 day (M–O), 4 days (P–R), 1 week (S–U), and 4 weeks
(V–X) after PONT. (G–I) The morphology of the Iba-1-positive cells under normal conditions. Most cell bodies of Iba-1-positive
cells were small with long and thin processes indicating resting microglia morphology in each third of the ON (arrows, H and I),
although occasionally one or two activated cells could been seen (arrowheads, I). (J–O) The morphology of the Iba-1-positive cells
12 h and 1 day after PONT. The cell bodies of Iba-1-positive cells became enlarged with shorter processes (partially activated cells,
arrowheads, K–M) or showed the spherical cell morphology (fully activated cells, arrows, J and O) at 12 h and 1 day after PONT.
(P–R) The morphology of the Iba-1-positive cells 4 days after PONT. Almost all of the activated microglia/macrophages showed a
spherical morphology (arrow), and some cells overlapped with each other to make the differentiation of individual cells difficult
(arrowheads). (S–U) Most cells remained in the fully activated state 1 week after PONT (arrows). (V–X) Until 4 weeks after
PONT, in addition to the spherical cells (arrows), some partially activated cells appeared again (arrowheads).
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upregulated during the activation of these cells. According
to Davis et al., the morphology of microglia can be divided
into three kinds according to various activity: ramified
appearance (resting cells), swollen ramified appearance (par-
tially activated cells), and spherical appearance (fully acti-
vated cells) (13). Our study showed that in the normal
condition, most cell bodies of Iba-1-positive cells were small
with long and thin processes, which indicated the morphol-
ogy of resting microglia (arrows, Fig. 6H, I), although
occasionally one or two activated cells could been seen
(arrowheads, Fig. 6I). However, the cell bodies of Iba-1-
positive cells became enlarged with shorter processes (par-
tially activated cells, arrowheads, Fig. 6K–M) or showed
the spherical cell morphology (fully activated cells, arrows,
Fig. 6J, O) at 12 h and 1 day after PONT. Four days after
PONT, almost all the activated microglia/macrophages
showed spherical morphology (arrow, Fig. 6P–R) and
some cells overlapped with each other to make the differ-
entiation of individual cell difficult (arrowheads, Fig. 6P,
Q). Most cells remained fully activated 1 week after PONT
(arrows, Fig. 6S–U). Until 4 weeks after PONT, in addi-
tion to the spherical cells (arrows, Fig. 6V–X), some par-
tially activated cells appeared again (arrowheads, Fig. 6V).
In addition to the transformation of the morphology, the
magnitudes of microglia/macrophages response, which were
represented by the ratios of the positive areas of Iba-1
labeling to the total stained areas, increased in the whole
ONs (4 days: 0.207 ± 0.029, 1 week: 0.087 ± 0.009, and
4 weeks: 0.088 ± 0.011), the dorsal ONs (4 days: 0.279 ±
0.045, 1 week: 0.142 ± 0.017, and 4 weeks: 0.149 ± 0.020),
and central ONs (4 days: 0.234 ± 0.041, 1 week: 0.087 ±
0.015, and 4 weeks: 0.073 ± 0.013) at 4 days, 1 week, and
4 weeks after PONT compared with normal rats (total:
0.031 ± 0.006, dorsal: 0.020 ± 0.004, and central: 0.038 ±
0.010), although the response magnitudes were similar
among the normal group, 12 h after PONT group, and 1 day
after PONT group in the whole ONs (normal: 0.031 ±
0.006, 12 h: 0.027 ± 0.011, and 1 day: 0.038 ± 0.005) and
each third of the ONs (Fig. 7A). In the dorsal areas, the
ratios in the normal, 12 h, and 1 day after PONT groups
were 0.020 ± 0.004, 0.047 ± 0.039, and 0.041 ± 0.008,
respectively. In the central areas, the ratios in the nor-
mal, 12 h, and 1 day after PONT groups were 0.038 ±
0.010, 0.026 ± 0.010, and 0.030 ± 0.008, respectively. In
the ventral areas, the ratios in the normal, 12 h, and 1 day
after PONT groups were 0.031 ± 0.010, 0.018 ± 0.004,
and 0.028 ± 0.003. In addition, the magnitude decreased
significantly from 1 week after PONT when compared with
the magnitude of 4 days after PONT in the whole ONs,
dorsal ONs, central ONs, and ventral ONs (Fig. 7A). In the
ventral ONs, the magnitude of Iba-1-positive labeling only
increased on the fourth day (0.099 ± 0.015) after PONT but
not on other time points after PONT (12 h: 0.018 ± 0.004,
1 day: 0.027 ± 0.003, 1 week: 0.038 ± 0.005, and 4 weeks:
0.038 ± 0.005) (Fig. 7A).
Then, when the response magnitudes in each third por-
tion (dorsal, central, and ventral) of the ON were com-
pared in the same group, the results showed that in
normal animals and animals 12 h and 1 day after PONT,
the ratios of Iba-1-positive labeling in each third were
similar (Fig. 7B). But 4 days and 1 week after PONT, the
ratios of positive labeling in the dorsal and central ONs were
similar and greater than that in the ventral ONs (Fig. 7B).
Four weeks after PONT, the ratio of Iba-1-positive label-
ing in the dorsal ON was greater than that in the central
and ventral ONs (Fig. 7B).
Effect of Lycium barbarum on the Response
of Microglia/Macrophages to PONT
The ratios of Iba-1-positive labeling areas of the whole
ONs were 0.031 ± 0.006, 0.137 ± 0.007, and 0.069 ± 0.015
in the normal, PBS, and LBP groups, respectively. In the
dorsal ONs, the ratios of Iba-1-positive labeling areas
were 0.020 ± 0.004, 0.182 ± 0.013, and 0.101 ± 0.017 in the
normal, PBS, and LBP groups, respectively. In the central
ONs, the ratios of Iba-1-positive labeling areas were 0.038 ±
0.010, 0.117 ± 0.015, and 0.068 ± 0.020 in the normal, PBS,
and LBP groups, respectively. In the ventral ONs, the
ratios of Iba-1-positive labeling areas were 0.031 ± 0.010,
0.059 ± 0.013, and 0.022 ± 0.008, respectively. The results
showed that LBP decreased the ratios of Iba-1-positive
labeling areas in the whole ONs, dorsal ONs, and central
ONs 4 weeks after PONT (Fig. 8A, B).
DISCUSSION
In this study, our results showed that LBP could
decrease secondary degeneration of axons in the ONs 4
weeks after PONT. In addition, microglia/macrophages
were activated in the whole ON (both primary and sec-
ondary injury sites) from 12 h after PONT and LBP
FACING PAGE
Figure 7. The ratios of the positive labeling areas of Iba-1 in whole ONs, dorsal ONs, central ONs, and ventral ONs. (A) Iba-1-
positive labeling areas increased from 4 days after PONT until 4 weeks after PONT in whole ONs, dorsal ONs, and central ONs,
but the magnitude decreased from 1 week after PONT. In the ventral ONs, Iba-1-positive labeling increased 4 days after PONT, but
not at other time points studied (one-way ANOVA, SNK test for multiple comparisons: #p < 0.001; ǂp < 0.001; *p < 0.05, n = 4 in
each group). (B) In normal animals and animals 12 h and 1 day after PONT, the ratios of Iba-1-positive labeling in the dorsal, cen-
tral, and ventral ONs were similar. However, at 4 days and 1 week after PONT, the ratios of positive labeling in the dorsal and cen-
tral ONs were similar and greater than those in the ventral ONs (one-way ANOVA, SNK test for multiple comparisons: #p < 0.001;
ǂp < 0.001; *p < 0.05; NS, no significance, n = 4 in each group).
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could alleviate the response magnitude of microglia/
macrophages 4 weeks after PONT.
The fruit of Lycium barbarum is a traditional medicine
in China, and it has long been used as a functional food as
well as for medicinal purposes. In Chinese medicine,
Lycium barbarum was recorded to have the efficacy to
nourish the liver and kidney and be good for the eye. Mod-
ern studies elucidate that extracts from Lycium barbarum
have a great number of biological activities in different ani-
mal models. These studies indicated that it had potential
effects against cancer (44,59), liver injury (12,51), over-
weight (1), cardiovascular diseases (52), and inflammatory
Figure 8. The ratios of Iba-1-positive labeling areas in normal, PBS, and LBP groups. (A) LBP decreased the ratios of Iba-1-positive
labeling in whole ONs, dorsal ONs, and central ONs 4 weeks after PONT (one-way ANOVA, SNK test for multiple comparisons:
#p < 0.001; ǂp < 0.001; *p < 0.05; NS, no significance, n = 4, 5, 5 in normal, PBS, and LBP groups, respectively). (B) The represen-
tative photographs from normal, PBS, and LBP groups (scale bar: 100 µm).
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diseases (44). It could also modulate immunity (47) and sex
behavior (27). In addition, Lycium barbarum has neuro-
protective roles (7,9,20–22,30,32,36,54,56). In an eye
study, our group showed that LBP could decrease secondary
degeneration but not primary degeneration of the cell bodies
of RGCs in the retinas after PONT (30). LBP could also
improve the function of other cell types in the outer retinas,
such as bipolar cells and photoreceptors, which were
affected secondarily to the PONT, in addition to inner retinas
(RGCs) (9). In this study, LBP was shown to decrease sec-
ondary degeneration in the central ONs rather than primary
degeneration in the dorsal ONs. Therefore, all our results
pointed to the fact that LBP could delay a variety of secondary
degeneration caused by PONT, including RGC bodies in the
inner retinas, secondary functional injury in the outer retinas,
and secondary degeneration of axons in the ONs. In addition,
our results showed that secondary degeneration mainly
occurred in the central ONs that were closer to primary injury
site rather than ventral ONs, which were further away from
the primary injury site 4 weeks after PONT. This result indi-
cated that secondary degeneration of axons in the ONs
occurred in a location-dependent pattern.
Although the densities of axons were similar among nor-
mal, PBS, and LBP groups in the ventral ON in this study,
marked morphological changes after PONT in the PBS
group were indicated by the decreased g-ratio. The decrease
in the g-ratio indicated a change in the ratio of axon diame-
ter to the fiber diameter and might be caused by the shrink-
age of the axons or the thickening of the myelin. However,
our study showed that no change in myelin thickness was
detected in the ventral ONs of the PBS group. Therefore, the
decrease in g-ratio was most likely due to a decrease in the
axon diameter in the ventral ON 4 weeks after PONT. The
decrease in the axon diameter might also indicate the dys-
function of the axons. Because no axon loss was detected in
the ventral ON by then, this result also indicated that the
morphological change and the dysfunction of axons preceded
the death of axons after PONT.
Oxidative stress and activation of microglia/macro-
phages occurred in the early stage after PONT, and the
former was precedent to the latter based on the cell
counting result of Iba-1-positive labeling (16). However,
they did not observe the morphological changes of
microglia/macrophages after PONT. The first aim of our
study was to detect if the time point of microglia/macro-
phage activation would be different based on the morpho-
logical change. The results in this experiment indicated
that the microglia were activated (shown by the transfor-
mation of morphology) in the whole ONs (both primary
and secondary injury sites) from 12 h after PONT, which
was earlier than that indicated by cell counting result (3
days after PONT) (16) or percentages of Iba-1-positive
labeling areas in our study (later than 1 day and earlier or
equal to 4 days after PONT). The response magnitudes of
microglia/macrophages were greatest 4 days after PONT in
the dorsal, central, and ventral ONs and then decreased.
But the activation of microglia/macrophages persisted in
the dorsal and central ONs until 4 weeks after PONT,
which was the longest time point investigated in our study.
At the same time, the magnitude returned to normal in the
ventral ONs. But the activation was possibly longer than 4
weeks in dorsal and central ONs and microglia/macro-
phages played a pivotal role in both primary and secondary
degeneration of axons in the ONs for a long period of time.
Microglia/macrophages were shown to be a source of free
radicals (4). Then our results indicated that microglia/mac-
rophages might be activated as early as the occurrence of
oxidative stress after PONT and be the source of ROS.
Our results also showed that LBP could decrease the
response of microglia/macrophages in both primary (dor-
sal ONs) and secondary injury sites (central ONs). The
activated microglia/macrophages are divided into two
subtypes: M1 and M2. The deleterious M1 cells produce
ROS and other harmful molecular effectors, such as pro-
inflammatory cytokines including interleukin (IL)-1b, IL-6,
IL-23, and tumor necrosis factor-a (4), but the beneficial
M2 cells have protective effects (4). It is reasonable to
hypothesize that LBP could decrease M1 cell number as
well as increase M2 cell number after PONT, since LBP
could decrease oxidative stress in the retinas after PONT
(30) and increase M2 cell number after spinal cord injury
(58). It would be interesting to study the numbers of M1
and M2 cells in the ONs from animals treated with LBP
after PONT in the future. Although LBP could decrease
the activation of microglia/macrophages in both primary
and secondary injury sites, only secondary degeneration of
axons in the central ONs was delayed by LBP but not pri-
mary degeneration in the dorsal ONs. A possible reason
was that the primary degeneration was caused by the direct
damage and too severe to be slowed down, although the
response of microglia/macrophages was inhibited to some
extent. In addition, additional mechanisms other than the
activation of microglia/macrophages, which could not be
modulated by LBP, could also take part in the primary
degeneration. This point needs further investigation.
In conclusion, our results showed that the time point
of microglia/macrophage activation based on the morphol-
ogy was much earlier than that based on quantitative anal-
ysis, and they might involve in oxidative stress after
PONT. LBP could decrease secondary degeneration of
axons by inhibiting the activation of microglia/macro-
phages 4 weeks after PONT. Therefore, LBP might be a
promising herbal medicine for treatment of secondary
degeneration in neurodegenerative diseases of the CNS.
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